Krpina, K.;                     Mavrinac, M.;                     Samarzija, M.;                     Tolic, E.;                     Darapi, D.;                     Baticic, L.    
        Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection. J. Clin. Med. 2022, 11, 6695.
    https://doi.org/10.3390/jcm11226695
    AMA Style
    
                                Krpina K,                                 Mavrinac M,                                 Samarzija M,                                 Tolic E,                                 Darapi D,                                 Baticic L.        
                Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection. Journal of Clinical Medicine. 2022; 11(22):6695.
        https://doi.org/10.3390/jcm11226695
    
    Chicago/Turabian Style
    
                                Krpina, Kristina,                                 Martina Mavrinac,                                 Miroslav Samarzija,                                 Ena Tolic,                                 Dora Darapi,                                 and Lara Baticic.        
                2022. "Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection" Journal of Clinical Medicine 11, no. 22: 6695.
        https://doi.org/10.3390/jcm11226695
    
    APA Style
    
                                Krpina, K.,                                 Mavrinac, M.,                                 Samarzija, M.,                                 Tolic, E.,                                 Darapi, D.,                                 & Baticic, L.        
        
        (2022). Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection. Journal of Clinical Medicine, 11(22), 6695.
        https://doi.org/10.3390/jcm11226695